Good Health & Medical News — new treatments, disease eliminations, and care reaching people who lacked it, gathered from small independent outlets on every continent, translated into English where needed and ranked by how much each story actually helps. The last three months; the live feed has everything.
Updated 2026-10-26 09:21 UTC · refreshed every 30 minutes · open the full live feed →
The World Health Organization has officially certified Egypt as having eliminated hepatitis C as a public health threat. This milestone marks a significant achievement in regional and global public health efforts to combat the virus. The certification confirms that the country has met the necessary thresholds to stop transmission and protect its population.
A large-scale clinical study has found that a simple liquid applied to teeth can stop cavities without the need for drills, injections, or anesthesia. This non-invasive, affordable treatment could prevent painful dental procedures for thousands of children.
Scientists in Vietnam have successfully developed a new-generation vaccine for Japanese encephalitis that demonstrates a high immune response. The team is currently completing the registration process to make the vaccine available for public use.
A simple liquid that can be painted onto teeth stops cavities without the need for drills, injections, or anesthesia. This inexpensive treatment successfully prevented decay in a major clinical trial, potentially sparing thousands of children from painful dental procedures.
A new clinical trial has launched to test a treatment for Ebola in the Democratic Republic of Congo. This initiative brings hope for controlling the outbreak, which has affected seven provinces across the nation. The medical effort represents a significant step in the ongoing fight against the virus.
A Phase III clinical trial shows that the drug divarasib significantly improves outcomes for patients with previously treated KRAS G12C-mutated lung cancer. The treatment reduced the risk of disease progression or death by 42% compared to earlier therapies.
A clinical trial demonstrates that a personalized mRNA vaccine combined with immunotherapy reduces the risk of melanoma returning by 42%. This represents a significant medical development in the application of mRNA technology to cancer treatment.
Researchers have successfully corrected a genetic mutation within the human body using a precise technique called 'prime editing'. In a clinical trial, the scientists corrected liver cells affected by Wilson disease, a rare disorder that prevents the body from removing excess copper. This breakthrough paves the way for faster and more affordable genetic therapies.
A personalized vaccine, used in combination with immunotherapy, cut the risk of death or cancer recurrence by 42% in a clinical trial involving over 1,000 patients. This medical advancement offers a promising new strategy for treating melanoma. The phase 3 results provide significant potential for improving outcomes for those diagnosed with the disease.
A large-scale Phase 3 clinical trial involving over 1,000 patients found that a personalized cancer vaccine combined with immunotherapy significantly improves outcomes for melanoma patients. The treatment successfully reduced the risk of disease recurrence or death by 42 percent, offering a major potential advancement in cancer care.
A study shows that a new mRNA-based cancer vaccine, when used with standard immunotherapy, reduces the risk of death or recurrence in melanoma patients by 42%. The promising results from this large clinical trial suggest a potential new path for personalized cancer treatment.
Researchers have successfully completed the third phase of clinical trials for a new vaccine designed to treat skin cancer. This advancement could provide an effective new treatment option for patients facing difficult diagnoses. The treatment is now moving toward final regulatory review.
Researchers have developed a world-first mRNA vaccine designed to treat melanoma skin cancer. The breakthrough, tested in an Australian-led clinical trial, offers a new pathway for managing advanced skin cancers.
Researchers in Sydney have successfully conducted the world's first major trial of a personalized therapeutic cancer vaccine. This breakthrough marks a significant shift in cancer treatment research, offering new possibilities for targeted patient care.
The government of Kyrgyzstan has increased funding for pediatric oncology services by 200 times. This significant investment aims to enhance medical care and treatment capacity for children battling cancer across the country.
Starting November 9, the cost of 137 essential cancer medications will be reduced by as much as 70%. This policy win aims to significantly lower the financial burden for patients undergoing cancer treatment across the country.
A clinical trial in China has demonstrated an 84% efficacy rate in treating advanced, metastatic cancer using an innovative iron-based therapeutic agent. Inspired by industrial wastewater treatment techniques, the method uses iron to generate hydroxyl radicals that target and degrade malignant tumor cells. This approach offers a potential new path for patients with limited remaining therapeutic options.
Advancements in targeted therapies and genetic-mutation testing have cut lung cancer death rates in half compared to the 1990s. These medical developments offer more effective, personalized options for patients.
The Gates Foundation and Wellcome Leap have committed $100 million to a new program called Uzima aimed at reducing global stillbirth rates. The initiative focuses on research and innovation to potentially cut stillbirth rates in half across select countries in sub-Saharan Africa.
The Indian government has capped trade margins for non-scheduled anti-cancer drugs at 30%, a move expected to reduce the price of vital medications by up to 70%. This intervention is estimated to save patients nationwide Rs 2,500 crore annually, significantly easing the financial burden for those seeking cancer treatment.
The 2026 Nobel Prize in Medicine has been awarded to Peter Hegemann, Georg Nagel, and Karl Deisseroth for their pioneering research in optogenetics. This field, which uses light to control the activity of neurons, has revolutionized neurobiological research and holds potential for future medical therapies.
Researchers at Macquarie University believe they have identified a potential cure for Parkinson's disease. The discovery marks a significant step forward in the effort to treat the neurodegenerative condition, which affects millions of people globally.
The World Health Organization has prequalified the Serum Institute of India's quadrivalent HPV vaccine, Cervavac. This milestone facilitates its distribution in global public health programs aimed at preventing cervical cancer. Access to this vaccine is a significant step in reducing mortality from the disease worldwide.
An Australian-led trial has identified an experimental drug that may reduce brain inflammation, potentially stopping the development of Parkinson's disease in high-risk patients. This breakthrough could provide a long-awaited medical intervention to slow or halt the progression of the condition before serious symptoms emerge.
The Asha Kirana program has successfully facilitated more than 250,000 cataract surgeries across the state of Karnataka. This massive outreach effort has significantly improved vision and quality of life for thousands of patients, particularly in underserved communities.
Scientists at UC San Francisco have developed a way to engineer cancer-fighting CAR-T cells directly inside a patient's body using a two-particle delivery system. This breakthrough could eventually replace the current, slow, and costly process that requires removing and reinfusing a patient's immune cells.
Doctors in China have developed a groundbreaking, non-invasive technique to shrink a life-threatening lung tumor in a fetus while still in the womb. This new approach allows for the treatment of a rare genetic condition without the risks of traditional surgery, offering a potential path to save thousands of infants annually.
The 2026 Nobel Prize in Physiology or Medicine has been awarded to three scientists for their groundbreaking work in optogenetics. This field uses light to control neurons, a technology that holds significant promise for future medical treatments. The discovery is considered a major milestone in modern biomedical science.
Karl Deisseroth, Peter Hegemann, and Georg Nagel have been awarded the Nobel Prize in Medicine for developing a method to control neurons using light. By inserting specific proteins into nerve cell membranes, they created a way to switch neurons on or off at will. This technique helps researchers study the brain's internal mechanisms and holds potential for developing new medical treatments.
The 2026 Nobel Prize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel for the development of optogenetics. This technology allows scientists to control neurons using light, offering a transformative method for treating neurological conditions and potentially restoring vision. The recognition highlights a major leap forward in neurobiology.
Researchers Peter Hegemann, Georg Nagel, and Karl Deisseroth have been awarded the Nobel Prize in Medicine for developing methods to study the inner workings of the brain. Their work enables new scientific understandings that are expected to advance the study and treatment of neurological conditions.
Researchers Karl Deisseroth, Peter Hegemann, and Georg Nagel have been awarded the 2026 Nobel Prize for their work on the relationship between light and brain function. Their findings in optogenetics provide significant new tools for understanding the brain's complex neural circuits. This discovery holds promise for future advancements in treating neurological disorders.
Scientists pioneering 'optogenetics' have been awarded the Nobel Prize in Physiology or Medicine for their ability to control specific neurons using light. This breakthrough offers new methods for understanding and treating a wide range of diseases by precisely managing neural circuits.
Three scientists have been awarded the Nobel Prize in Medicine for their pioneering discoveries in optogenetics and light-controlled ion channels. This research provides a transformative tool for neuroscientists to study and potentially treat neurological conditions by precisely controlling cell activity with light.
The Nobel Prize in Physiology or Medicine has been awarded to Karl Deisseroth, Peter Hegemann, and Georg Nagel. Their work in optogenetics, which uses light to control the activity of nerve cells, has opened new possibilities for neurological research and potential future treatments.
A clinical trial at the University of Chicago has successfully treated 12 participants for Type 1 diabetes using a combination of islet cell transplantation and a new anti-rejection medication. This breakthrough could eventually eliminate the need for daily insulin therapy for millions of patients. The researchers are continuing to monitor the long-term effectiveness of the procedure.
Mauritius has become the first nation in the world to report a statistically significant decrease in the prevalence of type 2 diabetes. This milestone follows years of coordinated public health efforts focused on diet, exercise, and screening programs.
The Dominican Social Security Council has approved full, no-copay coverage for 13 high-cost medications for patients with cancer, rare diseases, and immune disorders. This reform ensures essential treatments are accessible to thousands of citizens who previously faced prohibitive costs.
A Japanese hospital has successfully performed the world's first surgery transplanting heart muscle cells derived from iPS (induced pluripotent stem) cells into a patient. This procedure offers a new potential pathway for treating severe heart disease.
A medical team in Osaka successfully performed the world's first heart muscle surgery using iPS cell-derived sheets on a patient in her 50s. This breakthrough provides a new regenerative treatment path for patients suffering from severe heart failure. The procedure marks a significant milestone in practical clinical applications for regenerative medicine.